Firefly Neuroscience (NASDAQ:AIFF – Get Free Report) and Foresight Autonomous Holdings Ltd. American Depositary Shares (NASDAQ:FRSX – Get Free Report) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, valuation, earnings and dividends.
Earnings and Valuation
This table compares Firefly Neuroscience and Foresight Autonomous Holdings Ltd. American Depositary Shares”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Firefly Neuroscience | $110,000.00 | 284.40 | -$10.46 million | ($2.09) | -1.05 |
| Foresight Autonomous Holdings Ltd. American Depositary Shares | $400,000.00 | 9.52 | -$12.10 million | ($22.05) | -0.11 |
Volatility and Risk
Firefly Neuroscience has a beta of 1.92, meaning that its share price is 92% more volatile than the S&P 500. Comparatively, Foresight Autonomous Holdings Ltd. American Depositary Shares has a beta of 0.73, meaning that its share price is 27% less volatile than the S&P 500.
Profitability
This table compares Firefly Neuroscience and Foresight Autonomous Holdings Ltd. American Depositary Shares’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Firefly Neuroscience | -2,705.88% | -319.00% | -191.27% |
| Foresight Autonomous Holdings Ltd. American Depositary Shares | N/A | N/A | N/A |
Institutional & Insider Ownership
5.0% of Firefly Neuroscience shares are owned by institutional investors. Comparatively, 23.5% of Foresight Autonomous Holdings Ltd. American Depositary Shares shares are owned by institutional investors. 6.4% of Firefly Neuroscience shares are owned by company insiders. Comparatively, 10.6% of Foresight Autonomous Holdings Ltd. American Depositary Shares shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Analyst Recommendations
This is a summary of current ratings for Firefly Neuroscience and Foresight Autonomous Holdings Ltd. American Depositary Shares, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Firefly Neuroscience | 1 | 0 | 0 | 0 | 1.00 |
| Foresight Autonomous Holdings Ltd. American Depositary Shares | 1 | 0 | 0 | 0 | 1.00 |
Summary
Foresight Autonomous Holdings Ltd. American Depositary Shares beats Firefly Neuroscience on 7 of the 11 factors compared between the two stocks.
About Firefly Neuroscience
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
About Foresight Autonomous Holdings Ltd. American Depositary Shares
Foresight Autonomous Holdings Ltd., a technology company, engages in the development of smart multi-spectral 3D vision software solutions and cellular-based applications for the automotive industry in Israel, Japan, the United States, and internationally. It develops in-line-of-sight vision solutions and beyond-line-of-site accident-prevention solutions. The company also offers QuadSight automotive vision solution, a four-camera multi-spectral vision solution that combines two sets of stereoscopic infrared and visible-light cameras for obstacle detection; DynamiCal, an automatic calibration software solution to ensure that stereo cameras remain calibrated to create accurate and continuous 3D depth perception; and ScaleCam, a separated stereo camera solution. In addition, it provides Percept3D, a 3D point cloud solution that provides 3D raw data for obstacle detection, terrain analysis, and autonomous vehicle sensor fusion; and Mono2Stereo, a solution that enhances existing vision sensor systems by using software-based algorithms to create a 3D perception stereo vision solution. Further, the company offers Eye-Net Protect, a cellular-based V2X solution that provides real-time pre-collision alerts to various road users, such as pedestrians, cyclists, scooter drivers, etc. by using smartphones. Its solutions are used in automotive, defense, autonomous vehicles, and agriculture and heavy industrial equipment industries. The company was formerly known as Asia Development (A.D.B.M.) Ltd. and changed its name to Foresight Autonomous Holdings Ltd. in January 2016. Foresight Autonomous Holdings Ltd. is headquartered in Ness Ziona, Israel.
Receive News & Ratings for Firefly Neuroscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Firefly Neuroscience and related companies with MarketBeat.com's FREE daily email newsletter.
